Filing Details

Accession Number:
0001140361-15-016295
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-23 19:52:55
Reporting Period:
2015-04-23
Filing Date:
2015-04-23
Accepted Time:
2015-04-23 19:52:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501756 Avalanche Biotechnologies Inc. AAVL Biological Products, (No Disgnostic Substances) (2836) 205258327
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615096 Daniel Steven Schwartz C/O Avalanche Biotechnologies
1035 O'Brien Drive, Suite A
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-04-23 16,875 $38.62 436,181 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. This transaction was executed in multiple trades in prices ranging from $38.15 to $38.91, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.